Medifast, Inc. (MED) Misses Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.04 -1.87%
Revenue Growth %: -29.3%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -29.3%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q2 EPS of $0.38, $0.09 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $78.3 million versus the consensus estimate of $81.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Safe Bulkers (SB) Tops Q1 EPS by 7c
- Kroger meets earnings expectations, revenue tops estimates
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
